MCQ
Pharmaceutical Regulation MCQ - Practice Questions with Answers
Solve 3 Pharmaceutical Regulation questions for RAS/RPSC preparation.
Practice questions
Q1With reference to the MoU between the Indian Pharmacopoeia Commission and the Uttar Pradesh Pharma Council, consider the following statements: 1. It was signed on 14 July 2026 at India Expo Mart in Greater Noida. 2. Support for MSMEs through adverse-event reporting tools is outside its scope. Which of the statements given above is/are correct?
Statement 1 is correct: the MoU was signed on 14 July 2026 during the event at India Expo Mart in Greater Noida. Statement 2 is incorrect: the partnership expressly includes digital tools to help MSMEs report adverse events. Therefore, only statement 1 is correct.
Q2From which schedule of the Drugs Rules, 1945 has the Union health ministry removed cough syrups, ending their over-the-counter sale?
The Union health ministry amended the Drugs Rules, 1945, removing cough syrups from Schedule K, which covers drugs that can be sold over the counter without a prescription.
Q3Consider the following statements regarding the recent amendment to the Drugs Rules, 1945 on cough syrups:\n1. After the amendment, cough syrups can still be sold without a license in villages with fewer than 1,000 residents.\n2. Schedule K covers drugs that can be sold only by hospitals after laboratory testing.\nWhich of the statements given above is/are correct?
Statement 1 is false: the amendment removed the exemption, so cough syrups can now be sold in such villages only through licensed pharmacies complying with the Drugs and Cosmetics Act, 1940. Statement 2 is false: Schedule K covers drugs that can be sold over the counter without a prescription, not drugs requiring laboratory testing sold only by hospitals. Hence neither statement is correct.
You've seen 3 of 3 sample questions
Unlimited practice on Pharmaceutical Regulation comes with the RAS Test Series + Practice pack or Gate Pass.
